Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitor

BACKGROUND: Tumor growth rate (TGR), denoted as percentage change in tumor size per month, is a well-established indicator of tumor growth kinetics. The predictive value of early on-treatment TGR (EOT-TGR) for immunotherapy remains unclear. We sought to establish and validate the association of EOT-...

Descripción completa

Detalles Bibliográficos
Autores principales: He, L.-N., Fu, S., Ma, H., Chen, C., Zhang, X., Li, H., Du, W., Chen, T., Jiang, Y., Wang, Y., Zhou, Y., Lin, Z., Yang, Y., Huang, Y., Zhao, H., Fang, W., Zhang, H., Zhang, L., Hong, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808481/
https://www.ncbi.nlm.nih.gov/pubmed/36442353
http://dx.doi.org/10.1016/j.esmoop.2022.100630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808481/
https://www.ncbi.nlm.nih.gov/pubmed/36442353
http://dx.doi.org/10.1016/j.esmoop.2022.100630

Ejemplares similares